Symbol="CDTX"
AssetType="Common Stock"
Name="Cidara Therapeutics Inc"
Description="Cidara Therapeutics, Inc., a biotechnology company, is focused on the discovery, development, and commercialization of new long-acting anti-infectives for the treatment and prevention of disease in the United States. The company is headquartered in San Diego, California."
CIK="1610618"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="6310 NANCY RIDGE DRIVE, SUITE 101, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="73299000"
EBITDA="-8075000"
PERatio="None"
PEGRatio="0"
BookValue="0.171"
DividendPerShare="0"
DividendYield="0"
EPS="-0.12"
RevenuePerShareTTM="1.088"
ProfitMargin="-0.0892"
OperatingMarginTTM="-0.0969"
ReturnOnAssetsTTM="-0.0953"
ReturnOnEquityTTM="-2.025"
RevenueTTM="84567000"
GrossProfitTTM="-11232000"
DilutedEPSTTM="-0.12"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.225"
AnalystTargetPrice="5.6"
TrailingPE="-"
ForwardPE="1.785"
PriceToSalesRatioTTM="0.569"
PriceToBookRatio="3.949"
EVToRevenue="0.276"
EVToEBITDA="0.471"
Beta="1.24"
num_52WeekHigh="2.1"
num_52WeekLow="0.46"
num_50DayMovingAverage="1.061"
num_200DayMovingAverage="1.1"
SharesOutstanding="90025000"
DividendDate="None"
ExDividendDate="None"
symbol="CDTX"
open="0.80"
high="0.85"
low="0.80"
price="0.81"
volume="350592.00"
latest_trading_day="2023-08-18"
previous_close="0.81"
change="0.00"
change_percent="0.4689%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="62"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="38"
Volume_recent_avg="1113205"
Change_recent_avg="0.01"
Delta_recent_avg="0.08"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-0.29"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="38"
Aroon_momentum_negative="62"
image_negative_thumbnail_id_1="1140"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0173.jpeg"
image_negative_thumbnail_id_2="1134"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0167.jpeg"
image_neutral_thumbnail_id_1="531"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0068.jpeg"
image_neutral_thumbnail_id_2="568"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0031.jpeg"
image_positive_thumbnail_id_1="628"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0080.jpeg"
image_positive_thumbnail_id_2="972"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0134.jpeg"
image_professor_thumbnail_id_1="1178"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
image_professor_thumbnail_id_2="1196"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
